设为首页 加入收藏

TOP

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase](二十四)
2016-05-23 03:12:44 来源: 作者: 【 】 浏览:13043次 评论:0
a rapid motion straight into the skin at a 90 degree angle. Tape needle in place with sterile tape.

Repeat this step if you have a second infusion site.

Check for proper needle placement by pulling back on the syringe plunger to check for blood return in the tubing of the needle set.

If blood is seen in the tubing, remove and discard the subcutaneous needle and repeat steps 3, 5 and 6 with a new subcutaneous needle and infusion site.

Secure the needle set in place by applying a sterile protective dressing over the site. If more than one site is used, repeat the steps
1.
Administer the hyaluronidase (Labeled as “HY”):

Administer the HY at an initial rate per infusion site of approximately 1 to 2 mL per minute and increase as tolerated. Divide the contents equally between sites, if more than one site is used.

Remove the syringe from the needle set, after infusing all of the content of the syringe.

Attach the pump tubing or syringe filled with the IG to the same needle set.  
1.
Administer the immune globulin (Labeled as “IG”:
Within 10 minutes of completing the infusion of the HY, start the pump to administer the IG.


Flush infusion tubing up to the needle hub with normal saline or Dextrose 5% in water (D5W) at the end of infusion, if directed by your healthcare professional.  
1.
Remove subcutaneous needle(s) from the infusion site(s):

Remove the needle set by loosening the tape on all edges.

Pull the needle wings straight up and out.

Gently press a small piece of gauze over the needle site and cover with a dressing.

Throw away the needle(s) into the sharps container.  
1.
Record the infusion:

Remove the peel-off label from HYQVIA vial(s), which has the product lot number and expiration date, and place the label in your treatment record/ infusion log

Write down the date, time, dose, site(s) of infusion (to assist in rotating sites) and any reactions after each infusion.

Throw away the disposable supplies, vials, and unused product as recommended by your healthcare professional.  
Baxalta and Hyqvia are trademarks of Baxalta Incorporated.

Patented: please see www.baxalta.com/productpatents/

Baxalta US Inc.

Westlake Village, CA 91362 USA

U.S. License No. 2020

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Recombinant Human Hyaluronidase 1.25 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
1.25 mL
160 units per mL

Lot/Expiry date:

Recombinant Human Hyaluronidase 2.5 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
2.5 mL
160 units per mL

Lot:
Expiry date:

Recombinant Human Hyaluronidase 5 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
5 mL
160 units per mL

Lot:
Expiry date:
 
Recombinant Human Hyaluronidase 10 mL Infuse 1st Vial Label

Recombinant Human Hyaluronida

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 21 22 23 24 25 26 27 下一页 尾页 24/30/30
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇IMURAN(azathioprine)Tablets 下一篇ORTHO-CYCLEN ® and ORTHO TR..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位